Concepedia

Solène Géraudie

SG

Statistics

Publications

4

Citations

170

H-Index

4

Active since

2014

Affiliations

657 Oslo(Current)

Solène Géraudie is an author at 657 Oslo specializing in oncology, targeted therapy, and medicine.

Publications per year

2014–2019

4

Publications

4

Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer

Stefanie Hammer, Urs B. Hagemann, Sabine Zitzmann-Kolbe et al. · Clinical Cancer Research · 2019 · 121 citations · Full text

, , +17

Fully Human Antagonistic Antibodies against CCR4 Potently Inhibit Cell Signaling and Chemotaxis

Urs B. Hagemann, Lavinia Gunnarsson, Solène Géraudie et al. · PLoS ONE · 2014 · 23 citations · Full text

, , +17

Abstract 5200: Preclinical pharmacology of the PSMA-targeted thorium-227 conjugate PSMA-TTC: a novel targeted alpha therapeutic for the treatment of prostate cancer

Stefanie Hammer, Aasmund Larssen, Christine Ellingsen et al. · Cancer Research · 2017 · 15 citations

, , +17

Abstract 5859: HER2-targeted thorium-227 conjugate (HER2-TTC): Efficacy in preclinical models of trastuzumab and T-DM1 resistance

Jenny Karlsson, Urs B. Hagemann, Christoph A. Schatz et al. · Cancer Research · 2017 · 11 citations

, , +17

1–4 of 4